Literature DB >> 24925686

Effects of diphenyl diselenide on behavioral and biochemical changes induced by amphetamine in mice.

Fernanda Hernandes Figueira1, Caroline Queiroz Leal, Elizete de Moraes Reis, Jivago Röpke, Caroline Wagner, João Batista Teixeira da Rocha, Roselei Fachinetto.   

Abstract

Diphenyl diselenide (PhSe)2, an organoselenium compound, has been studied as a potential pharmacological agent in different in vitro and in vivo models, mainly due to its antioxidant properties. However, there are few studies concerning the effects of (PhSe)2 on dopaminergic system. Thus, the purpose of the present study was to evaluate the effects of acute and sub-chronic treatment of (PhSe)2 on amphetamine-induced behavioral and biochemical parameters. In acute protocol, mice were pre-treated with 5 or 10 mg/kg of (PhSe)2 and 30 min after, amphetamine was administered. In sub-chronic protocol, mice were pre-treated with 5 or 10 mg/kg of (PhSe)2 during 7 days and 24 h after, amphetamine was administered. Twenty-five minutes after amphetamine administration, behavioral (crossing, rearing, time of stereotypy and immobility) and biochemical (MAO activity, DCFH-DA oxidation, protein and non-protein thiol groups) parameters were analyzed. Amphetamine increased the number of crossing and rearing and (PhSe)2 prevented only the increase in the number of crossings when acutely administered to mice. Furthermore, amphetamine increased stereotypy and time of immobility in mice. (PhSe)2, at 10 mg/kg, increased per se the stereotypy and time of immobility when sub-chronically administered. (PhSe)2, at 10 mg/kg, potentiated the stereotypy caused by amphetamine in both protocols. Sub-chronic treatment with (PhSe)2 either alone (5 and 10 mg/kg) or in combination (10 mg/kg) with amphetamine decreased brain MAO-B activity. Oxidative stress parameters were not modified by (PhSe)2 and/or amphetamine treatments. In conclusion, sub-chronic administration of (PhSe)2 can promote a behavioral sensitization that seems to be, at least in part, dependent of MAO-B inhibition.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24925686     DOI: 10.1007/s00702-014-1257-4

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  35 in total

Review 1.  The therapeutic potential of monoamine oxidase inhibitors.

Authors:  Moussa B H Youdim; Dale Edmondson; Keith F Tipton
Journal:  Nat Rev Neurosci       Date:  2006-04       Impact factor: 34.870

2.  The effect of selenium on the central dopaminergic system: a microdialysis study.

Authors:  H R Rasekh; M D Davis; L W Cooke; E A Mazzio; R R Reams; K F Soliman
Journal:  Life Sci       Date:  1997       Impact factor: 5.037

3.  Striatal dopamine metabolism in monoamine oxidase B-deficient mice: a brain dialysis study.

Authors:  F Fornai; K Chen; F S Giorgi; M Gesi; M G Alessandri; J C Shih
Journal:  J Neurochem       Date:  1999-12       Impact factor: 5.372

4.  Diphenyl diselenide ameliorates behavioral and oxidative parameters in an animal model of mania induced by ouabain.

Authors:  César Augusto Brüning; Marina Prigol; Cristiane Luchese; Simone Pinton; Cristina Wayne Nogueira
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-03-20       Impact factor: 5.067

5.  Effects of diphenyl diselenide on depressive-like behavior in ovariectomized mice submitted to subchronic stress: involvement of the serotonergic system.

Authors:  Juliana Trevisan da Rocha; Bibiana Mozzaquatro Gai; Simone Pinton; Tuane Bazanella Sampaio; Cristina Wayne Nogueira; Gilson Zeni
Journal:  Psychopharmacology (Berl)       Date:  2012-03-27       Impact factor: 4.530

6.  Antidepressant-like effect of the novel MAO inhibitor 2-(3,4-dimethoxy-phenyl)-4,5-dihydro-1H-imidazole (2-DMPI) in mice.

Authors:  Jardel Gomes Villarinho; Roselei Fachinetto; Francielle de Vargas Pinheiro; Gabriela da Silva Sant'Anna; Pablo Machado; Patrícia Andréia Dombrowski; Cláudio da Cunha; Daniela de Almeida Cabrini; Marcos Antônio Pinto Martins; Helio Gauze Bonacorso; Nilo Zanatta; Maribel Antonello Rubin; Juliano Ferreira
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-04-17       Impact factor: 5.067

7.  Valeriana officinalis ameliorates vacuous chewing movements induced by reserpine in rats.

Authors:  Romaiana Picada Pereira; Roselei Fachinetto; Alessandro de Souza Prestes; Caroline Wagner; Jéssie Haigert Sudati; Aline Augusti Boligon; Margareth Linde Athayde; Vera Maria Morsch; João Batista Teixeira Rocha
Journal:  J Neural Transm (Vienna)       Date:  2011-04-08       Impact factor: 3.575

Review 8.  Food-chain selenium and human health: spotlight on speciation.

Authors:  Margaret P Rayman; Heidi Goenaga Infante; Mike Sargent
Journal:  Br J Nutr       Date:  2008-03-18       Impact factor: 3.718

9.  Monoaminergic agents modulate antidepressant-like effect caused by diphenyl diselenide in rats.

Authors:  Lucielli Savegnago; Cristiano R Jesse; Larissa G Pinto; Joao B T Rocha; Cristina W Nogueira; Gilson Zeni
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2007-05-25       Impact factor: 5.067

10.  Chronic treatment with fluphenazine alters parameters of oxidative stress in liver and kidney of rats.

Authors:  Cristiane L Dalla Corte; Roselei Fachinetto; Robson Puntel; Caroline Wagner; Cristina W Nogueira; Félix A Antunes Soares; João B T Rocha
Journal:  Basic Clin Pharmacol Toxicol       Date:  2009-04-16       Impact factor: 4.080

View more
  3 in total

1.  Selegiline acts as neuroprotective agent against methamphetamine-prompted mood and cognitive related behavior and neurotoxicity in rats: Involvement of CREB/BDNF and Akt/GSK3 signal pathways.

Authors:  Saba Feizipour; Sarvenaz Sobhani; Shafagh Mehrafza; Mina Gholami; Majid Motaghinejad; Manijeh Motevalian; Sepideh Safari; Reza Davoudizadeh
Journal:  Iran J Basic Med Sci       Date:  2020-05       Impact factor: 2.699

2.  Ex vivo and in vitro inhibitory potential of Kava extract on monoamine oxidase B activity in mice.

Authors:  Bárbara Nunes Krum; Catiuscia Molz de Freitas; Alcindo Busanello; Larissa Finger Schaffer; Roselei Fachinetto
Journal:  J Tradit Complement Med       Date:  2021-07-14

Review 3.  Toxicology and pharmacology of synthetic organoselenium compounds: an update.

Authors:  Cristina W Nogueira; Nilda V Barbosa; João B T Rocha
Journal:  Arch Toxicol       Date:  2021-04-01       Impact factor: 6.168

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.